When was Cellares founded?

Cellares was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is Cellares located?

Cellares is headquartered in San Francisco, United States.

Who is the current CEO of Cellares?

Fabian Gerlinghaus of Cellares. They have also founded 1 company.

How many employees does Cellares have?

As of May 31, 2026, the latest employee count at Cellares is 304.

Is Cellares a funded company?

Cellares is a funded company, having raised a total of $682M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 2019.

When was the latest funding round of Cellares?

Cellares' latest funding was a $***** Series D round on Jun 15, 2026, with participation from 0 investor.

Where does Cellares rank among its competitors?

Cellares ranks 2nd amongst 26 active competitors, of which 10 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Cellares, which secured $257M in Jan, 2026.

Who are the top competitors of Cellares?

Cellares' top competitors include Oribiotech, Multiply Labs and Cellular Origins. Among them, Cellares secured the most recent funding round in June, 2026.

Cellares - 2026 Company Profile, Team, Funding & Competitors

Cellares is a series D company based in San Francisco (United States), founded in 2019 by Alex Pesch, Fabian Gerlinghaus and Omar Kurdi. It operates as a Manufacturer of a medical device for cell-based therapy. Cellares has raised $682M in funding from investors like Eclipse, BlackRock and Decheng Capital. The company has 26 active competitors, including 10 funded and 1 that has exited. Its top competitors include companies like Oribiotech, Multiply Labs and Cellular Origins.

Company Details

Manufacturer of a medical device for cell-based therapy. The company offers Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. It also, offers software suite for cell therapy modalities.

Website: www.cellares.com/
Email ID: *****@cellares.com

Key Metrics

Founded Year

2019

Location

San Francisco, United States

Stage

Series D

Total Funding

$682M in 6 rounds

Latest Funding Round

Series D, Jun 15, 2026, $*****

Investors

Eclipse & 17 more

Ranked

2^nd among 26 active competitors

Employee Count

304 as on May 31, 2026

Similar Companies

Oribiotech & 25 more

View Cellares' full profile

Cellares has raised a total funding of $682M over 6 rounds. Its first funding round was on Aug 2019. Cellares has 18 institutional investors.

Here is the list of recent funding rounds of Cellares:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 15, 2026	8053139	Series D	4706789	8346541	5908922	8155336
Jun 09, 2026	7733940	Series D	3390089	9744115	9671641	ARK Investment Management
Jan 28, 2026	7914645	Series D	7109558	5626680	BlackRock & 1 more	T. Rowe Price & 10 more

Access funding benchmarks and valuations. Sign up today!

View details of Cellares's funding rounds and investors

The founders of Cellares are Alex Pesch, Fabian Gerlinghaus and Omar Kurdi. Fabian Gerlinghaus is the CEO of Cellares.

Here are the details of Cellares' key team members:

Alex Pesch: Co-Founder of Cellares and founder of 1 other company.
Contact Info: 1 email address
Fabian Gerlinghaus: Co-Founder & CEO of Cellares.
Contact Info: 1 email address
Omar Kurdi: Co-Founder of Cellares.
Contact Info: 1 email address

View details of Cellares's Founder profiles and Board Members

Cellares' employee count trend

Cellares has 304 employees as of May 26. Here is Cellares's employee count trend over the years:

Uncover Cellares' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cellares include Oribiotech, Multiply Labs and Cellular Origins. Here is the list of Top 10 competitors of Cellares, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oribiotech 2015, London (United Kingdom), Series B	Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool	$281M	Kindred Capital, Delin Ventures & 17 others	66/100
2nd	Cellares 2019, San Francisco (United States), Series D	Manufacturer of a medical device for cell-based therapy	$682M	Baillie Gifford, DFJ Growth & 16 others	64/100
3rd	Multiply Labs 2016, San Francisco (United States), Series A	Manufacturer of precision medicines through innovative robotic technology	$41.3M	Casdin Capital, Y Combinator & 22 others	64/100
4th	Cellular Origins 2022, Melbourn (United Kingdom), Series A	Provider of automated manufacturing solution for cell and gene therapy	$40M	Johnson & Johnson, The Technology Partnership ... & 3 others	55/100
5th	Astraveus 2016, Paris (France), Seed	Provider of a device for autologous cell and gene therapies	$18M	AdBio partners, Bpifrance & 5 others	55/100
6th	Celltrio 2018, Fremont (United States), Series B	Developer of automated biobanking and cell culture systems	$15M	Premier Partners	48/100
7th	Unicorn Biotechnologies 2020, Sheffield (United Kingdom), Seed	Developer of bioreactors for cell-based manufacturing	$3.2M	Climate Capital, HAX & 9 others	43/100
8th	Shenzhen Shenyan Biotechnology 2014, Shenzhen (China), Series B	Developer of automated cell processing system	$56.7M	Eight Roads Ventures, Asia Business Capital ... & 3 others	40/100
9th	ThermoGenesis 1986, Rancho Cordova (United States), Public	Provider of automated technologies for cell-based therapeutics and bio-processing	-	HHS, Bay City Capital	40/100
10th	Cell X Technologies 2017, Cleveland (United States), Funding Raised	Developer of regenerative medicine to measure and manage human cell sources	-	Innovation Works, HHS & 2 others	35/100